ovarian cancer subtypes may predict response to bevacizumab
Published 10 years ago • 841 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
0:54
dr. dowdy on the association of molecular subtypes and responses to bevacizumab in ovarian cancer
-
57:56
interactive webinar: what women need to know about ovarian cancer
-
5:56
mayo clinic awarded major grant for ovarian cancer research
-
6:07
dr. bakkum-gamez - preventive surgery for gynecologic cancers
-
5:22
recurrent ovarian cancer and clinical trials
-
19:58
gynecologic cancer education: surgical innovations
-
10:23
ovarian cancer: mayo clinic radio
-
10:11
mayo clinic q&a podcast: consider all ovarian cancer treatment options, including clinical trials
-
1:13
mayo clinic minute: ovarian cancer genes
-
2:16:24
mayo clinic impact symposium: ovarian cancer
-
1:05
dr. dowdy on bevacizumab and improvement of pfs in ovarian cancer
-
5:05
ovarian cancer - mayo clinic
-
1:58
ovarian cancer overview
-
2:53
ovarian cancer q & a
-
1:20
dr william cliby explains predictors of patient outcomes in ovarian cancer
-
1:19
dr. essel discusses adverse events of bevacizumab in ovarian cancer
-
48:45
gynecologic cancer education: immunotherapy & you
-
1:48
what are the subtypes of ovarian cancer?
-
10:07
ovarian cancer treatment options: mayo clinic radio